Axsome Therapeutics, Inc. (AXSM) vs Bruker Corporation (BRKRP)

A side-by-side comparison of Axsome Therapeutics, Inc. and Bruker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AXSM vs BRKRP

growth of $100 · dividends reinvested · last 1y
AXSM +42.3% (+42.3%/yr)BRKRP +94.8% (+94.8%/yr)BRKRP compounded faster over this window
100150200Start $1002026$142$195
AXSM BRKRP

AXSM vs BRKRP: by the numbers

  • •BRKRP is the larger company ($9.35B vs $9.04B market cap).
  • •Both run net losses; BRKRP's is the smaller (-2.03% vs -24.68% net margin).
  • •BRKRP pays a dividend (3.35% yield), while AXSM has no payments in the available dividend history.

Metrics side by side

Valuation

MetricAXSMBRKRP
Forward P/EN/A219.64
P/S ratio11.642.67
P/B ratio108.493.90
EV / EBITDAN/A31.07
FCF yieldN/A1.00%

Profitability

MetricAXSMBRKRP
Gross margin93.24%46.69%
Operating margin-24.28%3.61%
Net margin-24.68%-2.03%
ROE-230.05%-2.97%
ROIC-50.82%2.56%

Dividends

MetricAXSMBRKRP
Dividend yieldN/A3.35%

Growth (annualized)

MetricAXSMBRKRP
Revenue CAGR (5Y)N/A9.10%
FCF CAGR (5Y)N/A-21.33%
Total return CAGR (5Y)41.40%N/A

Frequently asked

Does AXSM or BRKRP pay a bigger dividend?
BRKRP pays a dividend (3.35% yield), while AXSM has no payments in the available dividend history.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.